Here are the 424B prospectus supplements from Biodesix, Inc. (BDSX) in our archive over the last 12 months, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow BDSX and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full BDSX filings page.
Biodesix, Inc. registers the resale of up to 375,000 shares of its common stock for the selling stockholder pursuant to registration rights.
The prospectus covers resale of shares issuable upon exercise of Perceptive’s warrant certificates and states the company will not receive proceeds from these resale transactions; cash proceeds would be received only if the warrants are exercised for cash.